The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3)
about
Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisPulmonary fibrosis: pathogenesis, etiology and regulationTargeting TGFβ signaling in subchondral bone and articular cartilage homeostasisAn osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDSTemporal characterization of the development of renal injury in FHH rats and FHH.1BN congenic strains.Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.Matrix vesicles: Are they anchored exosomes?Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone.Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.Regulation of matrix biology by matrix metalloproteinases.Matrix metalloproteinases as modulators of inflammation.TGF-beta1 on osteoimmunology and the bone component cellsTissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patientsAccumulation of exogenous activated TGF-β in the superficial zone of articular cartilage.Essential role of TGF-beta signaling in glucose-induced cell hypertrophy.1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases.Stromal Modulators of TGF-β in Cancer.Exploring anti-TGF-β therapies in cancer and fibrosis.The importance of matrix metalloproteinase-3 in respiratory disorders.Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.Intracellular signaling of cardiac fibroblasts.MMP dependence of fibroblast contraction and collagen production induced by human mast cell activation in a three-dimensional collagen lattice.A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligandsEffect of cigarette smoke on fibroblast-mediated gel contraction is dependent on cell density.Polyphosphate as a donor of high-energy phosphate for the synthesis of ADP and ATP.A mechanobiological model of orthodontic tooth movement.
P2860
Q28386047-0AE14DA3-273B-4002-8F61-E5C92F429EDCQ28388425-20320126-DB2B-45A3-A48C-C8A191159B86Q33760068-E273501F-D629-4AA9-B062-67E413B03F0FQ34125314-B1AE367E-3D5B-48E4-90E5-1D10A7139926Q34299797-2C61D16B-605D-418D-A535-A0ED35BFE842Q34599851-D13FFFF7-8C77-498E-B456-7E1B20B3CC22Q34784085-6643DBC3-6511-4097-8E65-13C4C30FEE63Q35235706-1D5C5AA9-FD02-47BB-AD88-2E21113C6101Q35850442-FB007B86-F0F7-4E4C-A245-B7F2095AF07FQ35854000-6C78E7C8-0B45-4B05-AFA1-6444C93E784AQ35861493-C1F97952-AFA0-4952-A4D2-7D53955FCC42Q35885655-3C313F90-F19E-46C4-B67A-77C330937187Q36449536-18CF617D-71D8-42CD-9B50-F533E19503DBQ36591727-47B7F1CD-7000-4FB3-B6AD-9AA52F15DB7DQ36610882-63A29E91-AC59-4B64-AC93-A4DD5B3B0B53Q36770447-478CE765-76B9-4C74-B7E2-A092392DEC0EQ37292388-6054999A-8BC2-4F18-AD8B-72A9643F983BQ37369232-4A2C02EE-C736-446F-A04A-DCFB84CE358CQ37628179-34C742D3-A5B2-4EEA-A0E2-0499F578FB8DQ37896073-D417ED3C-4198-4947-AE73-F133687C4EC6Q38215534-B9418677-D167-406D-97D4-0D15A5A0233BQ38364218-3620F037-E621-48A4-9801-20D7ECB07B56Q38423864-9BAFEF37-7EFB-4C4E-BB08-186C74E11D9CQ39908237-0817A350-0D08-4B9F-897E-9047F6E56255Q41991001-63698C9A-A533-465D-9582-B58E68B15D79Q44185712-908D340A-C7B2-4642-BE2D-4F29B526305CQ47948078-0E20696C-3275-460C-B98A-1609EE21FF32Q51374518-7EADCA7C-8530-41AC-87A8-66461D048144
P2860
The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3)
description
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Dezember 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/01/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/01/01)
@nl
наукова стаття, опублікована в січні 2002
@uk
مقالة علمية (نشرت عام 2002)
@ar
name
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@ast
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@en
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@nl
type
label
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@ast
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@en
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@nl
prefLabel
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@ast
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@en
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@nl
P2093
P356
P1476
The first stage of transformin ...... vesicle stromelysin-1 (MMP-3)
@en
P2093
P2888
P356
10.1007/S002230010032
P407
P577
2001-12-21T00:00:00Z
P6179
1003238772